Cardiol Therapeutics Inc - Class A

(OTC: CRTPF)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Cardiol Therapeutics Inc is a clinical-stage biotechnology company developing therapies for inflammatory heart disease. The company has received approval to commence a Phase II/III clinical trial investigating its product, CardiolRx, in COVID-19 patients with history of cardiovascular disease. CardiolRx is a pharmaceutically produced, GMP certified, THC free (<10 ppm) oral cannabidiol formulation.

Contact Information

Website: www.cardiolrx.com
Email: trevor.burns@cardiolrx.com
Main Phone: +1 289 910-0850
Address: 2265 Upper Middle Road East
Address 2: Suite 602
State: ON
City / Town: Oakville
Country: CA
Postal Code: L6H 0G5

Issuer Information

Exchange: OTCQX
CEO: David G. Elsley
Employees: 6
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A